Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
102 studies found for:    "glycogen storage disease type IX" OR "Glycogen Storage Disease"
Show Display Options
Download search resultsDownload the search results for:
"glycogen storage disease type IX" OR "Glycogen Storage Disease" (102 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Study of Glycogen Storage Disease and Associated Disorders
Condition: Glycogen Storage Disease
Intervention:
2 Completed Study of Glycogen Storage Disease Expression in Carriers
Condition: Glycogen Storage Disease
Intervention: Genetic: Glycogen Storage Disease markers
3 Recruiting The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)
Condition: Glycogen Storage Disease Type V
Interventions: Drug: Triheptanoin;   Other: Placebo oil
4 Recruiting Glycogen Storage Disease Type IV Database
Condition: Glycogen Storage Disease Type IV
Intervention: Other: No intervention
5 Terminated Clinical Evaluation of a Non-Invasive Hypoglycemia Detector in a Glycogen Storage Disease Population
Condition: Glycogen Storage Disease
Intervention: Device: Diabetes Sentry
6 Completed Overnight Feeding Study in Glycogen Storage Disease Type 1
Condition: Glycogen Storage Disease Type 1 (GSD 1)
Intervention: Other: overnight nutrition regime
7 Recruiting Glycosade v UCCS in the Dietary Management of Hepatic GSD
Condition: Glycogen Storage Disease
Intervention: Dietary Supplement: Medical Food - Glycosade
8 Completed
Has Results
Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease;   Glycogen Storage Disease Type Ia
Intervention: Other: Glycogen Storage Disease type Ia patients
9 Not yet recruiting Triheptanoin in Mc Ardle
Condition: Glycogen Storage Disease Type V
Interventions: Drug: Triheptanoin;   Drug: Placebo oil
10 Completed A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II
Conditions: Glycogen Storage Disease Type II;   Pompe Disease;   Acid Maltase Deficiency Disease;   Glycogenosis 2
Intervention: Drug: Alglucosidase alfa
11 Completed Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch
Conditions: Glycogen Storage Disease Type IA;   Glycogen Storage Disease Type IB;   Glycogen Storage Disease Type III;   Glycogen Storage Disease Type 0
Intervention: Dietary Supplement: Glycosade
12 Completed A Prospective, Observational Study in Patients With Late-Onset Pompe Disease
Condition: Glycogen Storage Disease Type II
Intervention:
13 Completed A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease
Condition: Glycogen Storage Disease Type II
Intervention: Biological: Myozyme
14 Completed Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602
Condition: Glycogen Storage Disease Type II
Intervention: Biological: Myozyme
15 Recruiting Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies
Condition: Glycogen Storage Disease Type III
Interventions: Dietary Supplement: FAXE Kondi;   Dietary Supplement: Faxe Kondi Free
16 Not yet recruiting Respiratory Muscle Training in LOPD
Condition: Glycogen Storage Disease Type II
Interventions: Device: RMT therapy using modified RMT device;   Device: Sham-RMT therapy using modified RMT device
17 Recruiting Effect of Motor Development, Motor Function and Electrophysiologic Findings of IOPD Under ERT
Condition: Glycogen Storage Disease Type II
Intervention: Other: observation study
18 Withdrawn High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe Disease
Condition: Glycogen Storage Disease Type II
Intervention: Other: High Protein and Exercise Therapy along-with Nocturnal Enteral Feeding
19 Completed Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies
Conditions: Pompe Disease Infantile-Onset;   Glycogen Storage Disease Type II
Intervention: Biological: Myozyme
20 Completed Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease
Conditions: Glycogen Storage Disease Type II;   Glycogenosis 2
Intervention: Biological: Myozyme

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.